The sold production of diagnostic reagents and other pharmaceutical preparations in Italy showed substantial variability from 2013 to 2022. The period started with a high value in 2013 but experienced significant year-on-year declines in 2014 and 2018. There was some recovery from 2019 onwards, with a notable increase in 2020. By 2023, the value stood at 404.71 million Euros, showing a moderate increase from 2022. Over the last five years, the compound annual growth rate (CAGR) was relatively modest at 2.62%.
Looking ahead from 2024 to 2028, the forecast suggests consistent but slow growth, with a 5-year CAGR of 0.82%. Future trends to watch for include potential advancements in diagnostic technology, shifts in pharmaceutical regulation, and the impact of global health initiatives on production levels.
